Life Science Company News

Results 1 - 20 out of 500 displayed.

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 »

Unlocking the Potential of Multi-Omics in Precision Medicine: A Conversation with Kazusa DNA Research Institute

By: PR Newswire Association LLC. - 07 Dec 2023

Related companies: MGI Tech Co., Ltd. (MGI) | MGI Tech Co., Ltd.

Abhasa Calls for More Drug Addiction Treatment Centers as India Faces Escalating Drug Abuse Crisis

By: PR Newswire Association LLC. - 07 Dec 2023

Vesper Bio doses first volunteer in Phase I study of first-in-class oral treatment for Frontotemporal Dementia (FTD)

By: PR Newswire Association LLC. - 07 Dec 2023

Related companies: Vesper Bio ApS

Strategic Radiology Grows Midwest Presence with Minnesota-based Regional Diagnostic Imaging

By: PR Newswire Association LLC. - 07 Dec 2023

Providence Medical Technology Announces New Publication Demonstrating High Fusion Rates and Successful Outcomes in Previously Failed Cervical Fusion Patients

By: PR Newswire Association LLC. - 07 Dec 2023

Trial Library, oncology clinical trial technology company, announces release of provider decision support platform to advance access to trials in community oncology settings

By: PR Newswire Association LLC. - 07 Dec 2023

Related companies: Trial Library, Inc.

Medit Unveils Enhanced Medit Link Software for Superior Scanner Performance

By: PR Newswire Association LLC. - 07 Dec 2023

Related companies: Meditope Biosciences, Inc. | Meditrina, Inc.

Visgenx and Charles River Announce Expansion of Gene Therapy Manufacturing Alliance

By: PR Newswire Association LLC. - 07 Dec 2023

Related companies: Visgenx, Inc.

Gilead Sciences Partners with the ISPE Foundation to Provide Grants to 93 Students and Recent Graduates

By: PR Newswire Association LLC. - 07 Dec 2023

Asia-Pacific Nucleic Acid Therapeutics CDMO Market Report 2023: Pharmaceutical Firms Becoming More Outsourcing-Oriented - Opportunity Forecasts to 2033

By: PR Newswire Association LLC. - 07 Dec 2023

Imlifidase demonstrated positive safety, tolerability, and early efficacy outcomes in 15-HMedIdeS-09 phase 2 trial in Guillain-Barré Syndrome (GBS)

By: PR Newswire Association LLC. - 07 Dec 2023

Related companies: Hansa Biopharma AB

Sectra leads the market in PACS considerations and selections

By: PR Newswire Association LLC. - 07 Dec 2023

Related companies: Sectra AB

ATMA and Cena Life Launch Nationwide Psychedelic-Assisted Therapy Healthcare Network

By: PR Newswire Association LLC. - 07 Dec 2023

Valtech Provides Biotechnology and Technology Startup Orientated Valuation Support

By: PR Newswire Association LLC. - 07 Dec 2023

Bioreactors Market size to grow by USD 2.23 billion from 2023 to 2028, Europe to account for 29% of market growth - Technavio

By: PR Newswire Association LLC. - 07 Dec 2023

Oligometastatic Disease Epidemiology Report, 2019-2032: Focus on United States, Germany, Spain, Italy, France, United Kingdom, and Japan

By: PR Newswire Association LLC. - 07 Dec 2023

Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine

By: PR Newswire Association LLC. - 07 Dec 2023

Related companies: Anixa Biosciences, Inc.

IonOpticks and Newomics broaden chromatography accessibility for Agilent mass specs, with Shimadzu pending

By: PR Newswire Association LLC. - 07 Dec 2023

Innovent Biologics and Synaffix Expand ADC Collaboration Following Positive Preliminary Clinical Signal from Ongoing Phase 1 Study

By: PR Newswire Association LLC. - 07 Dec 2023

Global Medical Gloves Strategic Market Report 2023-2030 with Top Glove Dominating the Multi-Billion Industry

By: PR Newswire Association LLC. - 07 Dec 2023

Results 1 - 20 out of 500 displayed.

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 »

Enhance your business development with Biotechgate

Try for free »